CEP120

Across TCGA pan-cancer cohorts, CEP120 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CEP120 data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CEP120 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CEP120 expression acts as an unfavorable survival marker.

LUAD and PDAC are the cancer types where CEP120 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.355	0.869	.046	2	view →
PDAC	OS	Quartile	III,IV	0.453	0.977	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CEP120–LUAD (OS)

Open the LUAD breakdown →